This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Summary
Thallous chloride Tl-201 is a radioisotope indicated for cardiac perfusion scintigraphy
- Generic Name
- Thallous chloride Tl-201
- DrugBank Accession Number
- DB16624
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved
- Structure
Structure for Thallous chloride Tl-201 (DB16624)
- Weight
- Average: 236.42
Monoisotopic: 235.9396565 - Chemical Formula
- ClTl
- Synonyms
- Thallium (201Tl) chloride
- Thallous chloride Tl 201
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Thallous Chloride Tl 201 Injection, powder, lyophilized, for solution 1 mCi/1mL Intravenous Medi-Physics, Inc. dba GE Healthcare 1982-02-01 Not applicable US 
Thallous Chloride Tl 201 Injection, solution 2 mCi/1mL Intravenous Lantheus Medical Imaging, Inc. 1977-12-16 Not applicable US THALLOUS CHLORIDE Tl 201 Injection, solution 1 mCi/1mL Intravenous Mallinckrodt Inc. 2012-02-29 2017-07-01 US THALLOUS CHLORIDE Tl 201 Injection, solution 1 mCi/1mL Intravenous Curium US LLC 2015-11-04 Not applicable US - Generic Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Thallous Chloride Tl 201 Injection, solution 2 mCi/1mL Intravenous Mallinckrodt, Inc. 2013-09-04 2013-09-05 US
Categories
- ATC Codes
- V09GX01 — Thallium (201tl) chloride
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3I8Y076A0E
- CAS number
- 55172-29-7
- InChI Key
- GBECUEIQVRDUKB-RYDPDVNUSA-M
- InChI
- InChI=1S/ClH.Tl/h1H;/q;+1/p-1/i;1-3
- IUPAC Name
- chloro(201Tl)thallane
- SMILES
- Cl[201Tl]
References
- General References
- BASG: Thalliumchlorid (201Tl) Curium Injektionslösung (Thallous chloride Tl-201) Intravenous Injection [Link]
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intravenous 37 MBq/ml Injection, powder, lyophilized, for solution Intravenous 1 mCi/1mL Injection, solution Intravenous 1 mCi/1mL Injection, solution Intravenous 2 mCi/1mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0.53 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 6.14 m3·mol-1 Chemaxon Polarizability 4.35 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at February 24, 2021 21:41 / Updated at January 02, 2022 10:33